Non-Applicability of Annual Secretarial Compliance Certificate for the year ended 31st March, 2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+5.5%1-day move

₹76.50

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+5.5+0.7+7.2+7.2+5.9+2.8—+7.2+0.7-4.6

Up moveDown movePending

AI summary

Ishita Drugs & Industries Ltd has informed BSE that it is not required to submit an Annual Secretarial Compliance Report under SEBI regulations for FY 2026. The company qualifies for exemption under Regulation 15(2) of SEBI (LODR) Regulations, 2015. As of 31st March 2025, the company's paid-up equity share capital was Rs. 2,99,03,000 (below Rs. 10 crore threshold) and net worth was Rs. 10,78,96,379 (below Rs. 25 crore threshold). This is a routine compliance notification informing the stock exchange of the exemption status.

Likely market impact

No material impact on shareholders. This is a routine regulatory filing confirming the company's exemption from secretarial audit requirements due to its small paid-up capital and net worth. The stock is unlikely to be affected by this notification.